丙氨酸氨基转移酶持续正常的慢性乙型肝炎诊疗专家共识

2021-08-15 中国研究型医院学会中国研究型医院. 2021,8(04)

本共识基于中国2019版慢性乙型肝炎防治指南，对丙氨酸氨基转移酶（ALT）持续正常的慢性乙型病毒性肝炎（CHB）的最新进展进行补充，旨在帮助临床医师在ALT持续正常CHB患者的诊治中做出合理的诊疗决策

中文标题：

发布机构：

中国研究型医院学会

发布日期：

2021-08-15

简要介绍：

本共识基于中国2019版慢性乙型肝炎防治指南，对丙氨酸氨基转移酶（ALT）持续正常的慢性乙型病毒性肝炎（CHB）的最新进展进行补充，旨在帮助临床医师在ALT持续正常CHB患者的诊治中做出合理的诊疗决策。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=db0d41c00216a899, title=丙氨酸氨基转移酶持续正常的慢性乙型肝炎诊疗专家共识 , enTitle=, guiderFrom=中国研究型医院. 2021,8(04), authorId=0, author=, summary=本共识基于中国2019版慢性乙型肝炎防治指南，对丙氨酸氨基转移酶（ALT）持续正常的慢性乙型病毒性肝炎（CHB）的最新进展进行补充，旨在帮助临床医师在ALT持续正常CHB患者的诊治中做出合理的诊疗决策, cover=https://img.medsci.cn/2021829/1630242860811_2020535.jpg, journalId=0, articlesId=null, associationId=1023, associationName=中国研究型医院学会, associationIntro=中国研究型医院学会，英文名称Chinese Research Hospital Association（CRHA），是经国家民政部正式批复并登记注册的全国性一级学会，是独立的法人社团。中国研究型医院学会是由以探索和建设研究型医院为目标的具有医疗服务、科学研究和临床教学“三位一体”功能的医疗机构，以及从事研究型医院理论与实践研究的人员自愿结成的全国性、专业性、学术性、非营利性社会组织。, copyright=0, guiderPublishedTime=Sun Aug 15 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">本共识基于中国2019版慢性乙型肝炎防治指南，对丙氨酸氨基转移酶（ALT）持续正常的慢性乙型病毒性肝炎（CHB）的最新进展进行补充，旨在帮助临床医师在ALT持续正常CHB患者的诊治中做出合理的诊疗决策。</span></p>, tagList=[TagDto(tagId=61, tagName=乙型肝炎)], categoryList=[CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=22, categoryName=肝病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=61, guiderKeyword=乙型肝炎, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5276, appHits=110, showAppHits=0, pcHits=372, showPcHits=5163, likes=0, shares=22, comments=5, approvalStatus=1, publishedTime=Sun Aug 29 22:36:28 CST 2021, publishedTimeString=2021-08-15, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Aug 29 21:14:31 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 13:13:09 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=丙氨酸氨基转移酶持续正常的慢性乙型肝炎诊疗专家共识_陈永平.pdf)])

丙氨酸氨基转移酶持续正常的慢性乙型肝炎诊疗专家共识_陈永平.pdf

下载请点击：

评论区 (4)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1065634, encodeId=e783106563410, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc365583438, createdName=ms9000000623894544, createdTime=Sun Oct 31 23:03:33 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015673, encodeId=ab0e10156e386, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48a74790591, createdName=chdb1986, createdTime=Wed Sep 08 13:01:04 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014319, encodeId=dff310143193e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210903/aa51d9b278404c4d9826c98300968a55/be70d8e157314c5daa40e7eac2d56898.jpg, createdBy=f2ce5593865, createdName=格雷, createdTime=Fri Sep 03 16:27:04 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012721, encodeId=022d1012e2197, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/e9408422a23545ef9738dd674abfc4ff/c719925083844b82986bc39d43051172.jpg, createdBy=8eb14795142, createdName=与狼共舞, createdTime=Mon Aug 30 06:46:03 CST 2021, time=2021-08-30, status=1, ipAttribution=)]
2021-10-31 ms9000000623894544

学习

51 0
[GetPortalCommentsPageByObjectIdResponse(id=1065634, encodeId=e783106563410, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc365583438, createdName=ms9000000623894544, createdTime=Sun Oct 31 23:03:33 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015673, encodeId=ab0e10156e386, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48a74790591, createdName=chdb1986, createdTime=Wed Sep 08 13:01:04 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014319, encodeId=dff310143193e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210903/aa51d9b278404c4d9826c98300968a55/be70d8e157314c5daa40e7eac2d56898.jpg, createdBy=f2ce5593865, createdName=格雷, createdTime=Fri Sep 03 16:27:04 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012721, encodeId=022d1012e2197, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/e9408422a23545ef9738dd674abfc4ff/c719925083844b82986bc39d43051172.jpg, createdBy=8eb14795142, createdName=与狼共舞, createdTime=Mon Aug 30 06:46:03 CST 2021, time=2021-08-30, status=1, ipAttribution=)]
2021-09-08 chdb1986

学习

61 0
[GetPortalCommentsPageByObjectIdResponse(id=1065634, encodeId=e783106563410, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc365583438, createdName=ms9000000623894544, createdTime=Sun Oct 31 23:03:33 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015673, encodeId=ab0e10156e386, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48a74790591, createdName=chdb1986, createdTime=Wed Sep 08 13:01:04 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014319, encodeId=dff310143193e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210903/aa51d9b278404c4d9826c98300968a55/be70d8e157314c5daa40e7eac2d56898.jpg, createdBy=f2ce5593865, createdName=格雷, createdTime=Fri Sep 03 16:27:04 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012721, encodeId=022d1012e2197, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/e9408422a23545ef9738dd674abfc4ff/c719925083844b82986bc39d43051172.jpg, createdBy=8eb14795142, createdName=与狼共舞, createdTime=Mon Aug 30 06:46:03 CST 2021, time=2021-08-30, status=1, ipAttribution=)]
2021-09-03 格雷

学习

71 0
[GetPortalCommentsPageByObjectIdResponse(id=1065634, encodeId=e783106563410, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc365583438, createdName=ms9000000623894544, createdTime=Sun Oct 31 23:03:33 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015673, encodeId=ab0e10156e386, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48a74790591, createdName=chdb1986, createdTime=Wed Sep 08 13:01:04 CST 2021, time=2021-09-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014319, encodeId=dff310143193e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210903/aa51d9b278404c4d9826c98300968a55/be70d8e157314c5daa40e7eac2d56898.jpg, createdBy=f2ce5593865, createdName=格雷, createdTime=Fri Sep 03 16:27:04 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012721, encodeId=022d1012e2197, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/e9408422a23545ef9738dd674abfc4ff/c719925083844b82986bc39d43051172.jpg, createdBy=8eb14795142, createdName=与狼共舞, createdTime=Mon Aug 30 06:46:03 CST 2021, time=2021-08-30, status=1, ipAttribution=)]
2021-08-30 与狼共舞

认真学习

71 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

传染科指南

丙氨酸氨基转移酶持续正常的慢性乙型肝炎诊疗专家共识

相关指南

拓展阅读

科室

工具

服务